These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 1363166

  • 1. [Currents aspects of H2 receptor antagonists in the treatment of ulcers].
    Debongnie JC.
    Acta Gastroenterol Belg; 1992; 55(5-6):415-22. PubMed ID: 1363166
    [Abstract] [Full Text] [Related]

  • 2. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E.
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Price AH, Brogden RN.
    Drugs; 1988 Nov; 36(5):521-39. PubMed ID: 2905640
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ, Fennerty B, Fagan TC.
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [Abstract] [Full Text] [Related]

  • 9. Histamine H2-receptor antagonists.
    Pounder R.
    Baillieres Clin Gastroenterol; 1988 Jul; 2(3):593-608. PubMed ID: 2901868
    [Abstract] [Full Text] [Related]

  • 10. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B, Müller P, Dammann HG.
    Wien Med Wochenschr; 1982 May 31; 132(10):223-8. PubMed ID: 6126962
    [Abstract] [Full Text] [Related]

  • 11. H2-receptor antagonists: development and application.
    Feldman S.
    N Engl Reg Allergy Proc; 1986 May 31; 7(4):362-6. PubMed ID: 2886903
    [Abstract] [Full Text] [Related]

  • 12. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
    Langtry HD, Grant SM, Goa KL.
    Drugs; 1989 Oct 31; 38(4):551-90. PubMed ID: 2573505
    [Abstract] [Full Text] [Related]

  • 13. Recent advances in the treatment of digestive diseases.
    Sun HS.
    J Int Med Res; 1989 Oct 31; 17 Suppl 1():2A-8A. PubMed ID: 2566540
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.
    Deakin M, Williams JG.
    Drugs; 1992 Nov 31; 44(5):709-19. PubMed ID: 1280563
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W.
    J Int Med Res; 1989 Nov 31; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [Abstract] [Full Text] [Related]

  • 18. [Nizatidine].
    Romero M, Franzosi MG.
    Medicina (Firenze); 1989 Nov 31; 9(1):93-6. PubMed ID: 2567957
    [Abstract] [Full Text] [Related]

  • 19. Ranitidine: a pilot study in Japan.
    Takemoto T, Okazaki Y, Okita K, Namiki M, Ishikawa M, Oshiba S, Kurokawa K.
    Scand J Gastroenterol Suppl; 1981 Jun 31; 69():125-8. PubMed ID: 6119776
    [Abstract] [Full Text] [Related]

  • 20. [The status of H2-blocker therapy today].
    Rameis H.
    Wien Med Wochenschr; 1992 Jun 31; 142(18):398-405. PubMed ID: 1362029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.